Aquilion system offers industry’s largest bore and widest field-of-view, potentially augmenting radiation therapy planning.
Canon Medical Systems received clearance from the U.S. Food & Drug Administration (FDA) Thursday for its Aquilion™ Exceed LB CT system that is designed to improve the planning and delivery of radiation therapy.
As an artificial intelligence-powered system, company officials said, Aquilion is intended to facilitate workflow while maintaining image quality and reproducibility.
Aquilion Exceed LB CT system. Credit: Canon Medical Systems USA, Inc.
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, CT business unit managing director for Canon Medical. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”
Based on company details, Aquilion offers several benefits:
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.